Skip to content

Combating Opioid Dependence

Combating Opioid Dependence

The opioid epidemic is a hot topic across the United States, along with the alternatives that could alleviate the tragic consequences the epidemic brings. Opioids, also known as narcotics, are strong prescription pain relievers such as oxycodone, hydrocodone and fentanyl. Although illegal, heroin is also considered to be an opioid. Most patients are introduced to these strong narcotics after a major injury or surgery and should only use them on a short-term basis. Unfortunately, this short-term timeline is not always followed, and the patient can become dependent on the pain killers for everyday life.

Understanding Opioid Dependence

Every day, more than 130 people in the United States die from an opioid overdose – including prescription pain relievers, heroin and synthetics. See below for additional facts we’ve uncovered regarding the opioid crisis:

  • Roughly 21-29% of patients prescribed opioids for chronic pain misuse them
  • Between 8-12% develop an opioid use disorder
  • An estimated 4-6% who misuse prescription opioids transition to heroin
  • About 80% of people who use heroin first misused prescription opioids

Ultimately, the opioid epidemic has become a severe national crisis that affects public health as well as social and economic welfare. Not only does the devastating issue carry consequences like an increase in opioid misuse and related overdoses, it’s also a catalyst for neonatal abstinence syndrome due to opioid use during pregnancy. As more opioid users turn to something stronger, like heroin, an increase in injection drug use follows, contributing to the spread of infectious diseases such as HIV and hepatitis C.

A Better Option

Both prescription opioids and cannabis have the same primary use: analgesia – the inability to feel pain. Currently, up to 90% of patients in state-level medical cannabis registries list chronic pain as their qualifying condition. According to a review conducted by the National Academies of Science and Medicine, when given access to cannabis, patients currently using opioids for chronic pain decreased their use by 40-60% and reported that they prefer cannabis rather than opioids. Patients also reported fewer side effects with cannabis and a better quality of life compared to opioids. 

Although there is minimal clinical literature that supports the use of cannabis as a treatment for acute pain, there is a long-standing body of pre-clinical evidence that demonstrates the effectiveness of cannabinoids in providing a pain-free life in drug-naïve animals.

“The mechanisms of cannabinoid antinociception are remarkably similar to those of opioid analgesics. Both the CB1 and MOR are G-protein coupled receptors, and agonist-initiated disinhibition of GABA release in the descending pain pathway is just one example of overlapping antinociceptive mechanisms between these drugs.” -NCBI.gov

The evidence we do have that supports the role of cannabis in acute, nonsevere pain management could lead to a substantial reduction in opioid prescription use. This increase in medical marijuana use for treating acute pain could eliminate patients being exposed to the risks of opioid dose escalation and physical dependence. We still have a long way to go, but the potential impact of this therapy definitely warrants further exploration of the efficacy of cannabis for pain relief and eliminating opioid dependence.

Interested in learning more about medical cannabis efficacies for opioid dependence or other qualifying conditions? Join Arfinn Med for FREE today to access HIPAA compliant peer-to-peer data on medical marijuana treatment efficacies, discuss treatment plans with other licensed physicians and stay up-to-date on all of the latest industry findings.

Sources: https://medlineplus.gov/healthtopics/opioidabuseandaddiction_b.html?utm_expid=.YDctbaKlRwemM6rjn-4YCA.2&utm_referrer=https%3A%2F%2Fwww.google.com%2F

https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135562/

Stories you may be interested in

The Lack of Clinical Trials in the Medical Marijuana Industry

As time goes on, medical marijuana is starting to break barriers in various states across the country. Out of the 50 states, 33 have approved a comprehensive medical marijuana program (NCSL). Currently, marijuana, medical or recreational, is illegal at the federal level, despite legalization in various states. Many medical professionals are interested in prescribing medical…
Read More

Older adults and medical marijuana: Reduced stigma and increased use

As a primary care doctor who has incorporated medical cannabis into his practice, it is notable how many silver-haired patients are coming in to discuss the pros and cons of a trial of medical cannabis. These patients range from people in their 60s with kidney failure who can no longer take certain pain medications but…
Read More

Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois

ABSTRACT Objectives To assess health-related outcomes associated with medical cannabis use among older patients in Colorado and Illinois enrolled in their home state’s medical cannabis program. Methods Cross-sectional data from anonymous surveys were collected from 139 persons over the age of 60 using medical cannabis in the past year. We used structural equation modeling (SEM)…
Read More

Florida doctors face new rules for medical marijuana (And how Arfinn Med can help)

TALLAHASSEE, Fla. – New rules laying out the do’s and don’ts physicians must follow when certifying patients to smoke medical marijuana took effect last week, but it’s not clear that doctors or patients are fully aware of them. Patients certified or recertified to smoke medical marijuana must sign a new standardized consent form as of last…
Read More

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

Alternative Mississippi medical marijuana program barely wins approval from Senate

JACKSON • Legislation that would create a new medical marijuana program in Mississippi if the voter-approved Initiative 65 is overturned in court cleared the state Senate on the second try last week early on Friday morning. Senate Bill 2765, the Mississippi Medical Cannabis Act, failed by a single vote Thursday evening. But six hours later, after…
Read More

Leave a Comment

You must be logged in to post a comment.